Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy

Cancer immunotherapy is a novel therapeutic regimen because of the specificity and durability of immune modulations to treat cancers. Current cancer immunotherapy is limited by some barriers such as poor response rate, low tumor specificity and systemic toxicities. Porous nanomaterials (PNMs) posses...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Su-Ran, Huo, Fang-Yi, Wang, Han-Qi, Wang, Jing, Xu, Chun, Liu, Bing, Bu, Lin-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195345/
https://www.ncbi.nlm.nih.gov/pubmed/35701847
http://dx.doi.org/10.1186/s12951-022-01489-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195345/
https://www.ncbi.nlm.nih.gov/pubmed/35701847
http://dx.doi.org/10.1186/s12951-022-01489-4

Ejemplares similares